SOURCE: Vascular Pathways, Inc.
NAPLES, FL--(Marketwired - February 20, 2014) - Vascular Pathways, Inc., a privately held medical device manufacturer with a revolutionary product for peripheral intravenous access, today announced that the company has appointed Thomas Grifa as Vice-President Manufacturing.
Thomas Grifa is a senior manufacturing executive with over 25 years of experience in the medical device industry. He has recently worked with several start-up and established organizations as a consultant focused on process improvements, new product introductions, and new process developments in off-shore locations. During his 25+ year career, Thomas has held various positions of increasing responsibility, including the Director of Engineering at Baxter Healthcare, in which he managed both the manufacturing engineering and the R&D engineering activities, as well as the Senior Vice President of Manufacturing for Covidien's International Division, in which he managed 20 manufacturing facilities with 8500 people located throughout Europe, Asia, Africa, and Latin America. Thomas is a strategic and operational leader with a highly successful career, having played a key role in growing revenues, increasing operational efficiencies, reducing costs, and bringing new products to the market. His accomplishments have been achieved by leveraging several key personal assets, including his global cultural and operational intelligence gained while running and implementing manufacturing organizations, engineering organizations, and strategic planning for several businesses. His training in both lLean manufacturing and Six Sigma has aided his success in creating world class manufacturing environments for several businesses.
"We are very excited to have Thomas Grifa join Vascular Pathways to provide manufacturing leadership for the AccuCath™ IV catheter line," said Bill Bold, Vascular Pathways Acting CEO. "We look forward to his guidance in focusing on opportunities to improve outcomes for healthcare providers and patients across the U.S. and internationally."
The AccuCath™ Intravenous Catheter System was developed by Dr. Amir Belson, Vascular Pathways' Founder, and offers a unique wire guidance system using AccuTip™ nitinol guidewire technology with the potential to improve clinical outcomes through first attempt PIV success and less traumatic vessel entry. "I look forward to contributing to the success of the AccuCath™ line, and I'm honored to be part of the team working on this revolutionary product," commented Grifa.
About Vascular Pathways, Inc.
Vascular Pathways is a private medical device company founded in 2005 which is commercializing the AccuCath™ Intravenous Catheter System, an FDA approved innovative product enabling rapid, safe, and successful IV insertion. For further information about Vascular Pathways or the AccuCath™ IV catheter line, please visit vascularpathways.com or call 239-254-0391.